January 15, 2023
Webinars
EHI & IBM Watson Health

The Current and Future State of Digital Health Credentials: Here to Stay

Overview
Although digital health credentials are not new, they rose quickly to international attention in the wake of the COVID-19 pandemic and have stayed in the news.

Hear from experts in healthcare and health technology about where things stand now with respect to their benefits, at-times controversial implementation, ethical and privacy implications — and where we go from here.

Speakers

  • Sunil Budhrani, MD, MPH, MBA, Chief Executive Officer & Chief Medical Officer, Innovation Health
  • Quentin Palfrey, President, International Digital Accountability Council (IDAC)
  • Eric Piscini, Global VP Payer and Emerging Business Networks, IBM Watson Health
  • Gautam M. Shah, Vice President, Platform and Marketplace, Change Healthcare








Related Resources


Webinars


Telehealth for Diabetes Care: A Program and Policy Framework
April 25, 2024
ATA
Discover the transformative power of telehealth for diabetes management, from education and prevention to comprehensive care, as evidenced by the success stories from various programs. This enlightening webinar delves into the significant impact of telehealth on both preventing and managing diabetes, along with the evolving landscape of policies shaping its future.

   View Video
Webinars
Maximizing Provider Capacity and Improving Access with Asynchronous Care
April 5, 2024
ATA's Async Telehealth Special Interest Group
With increasing provider shortages, patient wait times, and physician burnout, maximizing clinical capacity has become more critical than ever. Discover why leading direct-to-consumer health brands and provider organizations are turning to the power of asynchronous care to address these challenges.

   View Video
Webinars


Policy Update: Navigating the DEA's Geographic Red Flag in Remote Prescribing
March 29, 2024
ATA
This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.

   View Video